These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 23141970

  • 1. Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors.
    Zhang X, Han X, Dai D, Bao M, Zhang Z, Zhang M, Bice T, Zhao M, Cao Y, Shang H.
    Braz J Infect Dis; 2012; 16(6):510-6. PubMed ID: 23141970
    [Abstract] [Full Text] [Related]

  • 2. Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma.
    Humbert M, Antoni S, Brill B, Landersz M, Rodes B, Soriano V, Wintergerst U, Knechten H, Staszewski S, von Laer D, Dittmar MT, Dietrich U.
    Eur J Immunol; 2007 Feb; 37(2):501-15. PubMed ID: 17236253
    [Abstract] [Full Text] [Related]

  • 3. Selection and immune recognition of HIV-1 MPER mimotopes.
    Wieczorek L, Peachman K, Steers N, Schoen J, Rao M, Polonis V, Rao V.
    Virology; 2020 Nov; 550():99-108. PubMed ID: 32980676
    [Abstract] [Full Text] [Related]

  • 4. Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library.
    Zhou M, Meyer T, Koch S, Koch J, von Briesen H, Benito JM, Soriano V, Haberl A, Bickel M, Dübel S, Hust M, Dietrich U.
    Eur J Immunol; 2013 Feb; 43(2):499-509. PubMed ID: 23180650
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
    Braibant M, Brunet S, Costagliola D, Rouzioux C, Agut H, Katinger H, Autran B, Barin F.
    AIDS; 2006 Oct 03; 20(15):1923-30. PubMed ID: 16988513
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Collection of phage-peptide probes for HIV-1 immunodominant loop-epitope.
    Palacios-Rodríguez Y, Gazarian T, Rowley M, Majluf-Cruz A, Gazarian K.
    J Microbiol Methods; 2007 Feb 03; 68(2):225-35. PubMed ID: 17046088
    [Abstract] [Full Text] [Related]

  • 8. [Identification of human monoclonal HIV-1-neutralizing antibodies from phage antibody library by cell-based screening].
    Zhang N, Man L, Sun JP, Meng JZ, He YX.
    Bing Du Xue Bao; 2013 Sep 03; 29(5):471-9. PubMed ID: 24386834
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP, Geyer SJ, Hanson CV, Hendry RM, Milman G.
    AIDS; 1994 Feb 03; 8(2):169-81. PubMed ID: 7519019
    [Abstract] [Full Text] [Related]

  • 12. Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12.
    Karpenko LI, Scherbakova NS, Chikaev AN, Tumanova OY, Lebedev LR, Shalamova LA, Pyankova OG, Ryzhikov AB, Ilyichev AA.
    Mol Immunol; 2012 Apr 03; 50(4):193-9. PubMed ID: 22341130
    [Abstract] [Full Text] [Related]

  • 13. Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.
    Chikaev AN, Bakulina AY, Burdick RC, Karpenko LI, Pathak VK, Ilyichev AA.
    PLoS One; 2015 Apr 03; 10(3):e0120847. PubMed ID: 25785734
    [Abstract] [Full Text] [Related]

  • 14. Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice.
    Zhou M, Kostoula I, Brill B, Panou E, Sakarellos-Daitsiotis M, Dietrich U.
    Vaccine; 2012 Mar 02; 30(11):1911-6. PubMed ID: 22269872
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.
    Marcelino JM, Borrego P, Nilsson C, Família C, Barroso H, Maltez F, Doroana M, Antunes F, Quintas A, Taveira N.
    AIDS; 2012 Nov 28; 26(18):2275-84. PubMed ID: 23151495
    [Abstract] [Full Text] [Related]

  • 18. [Role of the HIV-1 gp120 V1/V2 domains in the induction of neutralizing antibodies].
    Granados-González V, Piedrahita LD, Martínez M, Genin C, Riffard S, Urcuqui-Inchima S.
    Enferm Infecc Microbiol Clin; 2009 Nov 28; 27(9):523-30. PubMed ID: 19409660
    [Abstract] [Full Text] [Related]

  • 19. Increased sensitivity of HIV variants selected by attachment inhibitors to broadly neutralizing antibodies.
    Zhou N, Fan L, Ho HT, Nowicka-Sans B, Sun Y, Zhu Y, Hu Y, McAuliffe B, Rose B, Fang H, Wang T, Kadow J, Krystal M, Alexander L, Colonno R, Lin PF.
    Virology; 2010 Jul 05; 402(2):256-61. PubMed ID: 20400170
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.